SC Filed 2019-07-23 Event — SEC 0000935836-19-000395 →

Stonepine Capital Management, LLC → VIVEVE MEDICAL, INC.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

10 filings by this filer

9 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on VIVEVE MEDICAL, INC.

Filed	Form	Filer	Stake	Shares
2019-06-26	SC	5AM Ventures II LP	—	—	view →
2019-03-20	SC	STONEPINE CAPITAL, L.P.	—	—	view →
2018-02-12	SC	Stonepine Capital Management, LLC	—	—	view →

Other Filings by Stonepine Capital Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-08-31	SCHEDULE 13G	Femasys Inc	—	—	view →
2026-08-26	SCHEDULE 13G	Edesa Biotech, Inc.	—	—	view →
2026-08-25	SCHEDULE 13G	CalciMedica, Inc.	—	—	view →
2026-07-21	SCHEDULE 13G	AEON Biopharma, Inc.	—	—	view →
2026-06-23	SCHEDULE 13G	Pasithea Therapeutics Corp. KTTAW	—	—	view →
2026-06-22	SCHEDULE 13G	Azitra, Inc. AZTR	—	—	view →
2026-06-16	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →
2026-06-09	SCHEDULE 13G	SINTX Technologies, Inc. SINT	—	—	view →
2018-02-12	SC	VIVEVE MEDICAL, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →